The Immunoinhibitory PD-1/PD-L1 Pathway in Inflammatory Blood Vessel Disease

Journal of Leukocyte Biology - United States
doi 10.1189/jlb.3ma0717-283
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

Blocking the PD-1/PD-L1 Pathway in Glioma: A Potential New Treatment Strategy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

The Importance of the PD-1/PD-L1 Pathway at the Maternal-Fetal Interface

BMC Pregnancy and Childbirth
GynecologyObstetrics
2019English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology
AllergyImmunology
2019English

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion

Journal of Biomedicine and Biotechnology
2011English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets

Advances in Bioscience and Biotechnology
2013English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

High-Affinity PD-1 Molecules Deliver Improved Interaction With PD-L1 and PD-L2

Cancer Science
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy